Recent studies raised the alarm that the inhibition of sodium-coupled glucose transporter type-2 in humans increases endogenous glucose production rates by an unclear mechanism. Surprisingly, a potential explanation may be linked directly to the alpha-cell. Is this a mechanistic spoiler or an added benefit?
Keywords: HNF4alpha; SGLT-2 inhibitors; alpha-cell; glucagon; glucose production.
Copyright © 2015 Elsevier Ltd. All rights reserved.